Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Cancer
|
July 15, 2009
The search for meaning-symptoms and transvaginal sonography screening for ovarian cancer: silent no more
Ilana Cass
JAMA Network Open
|
March 31, 2026
Patient Preferences for Ovarian Cancer Risk-Reducing Treatments Revealed Through Choice Experiments
Ilana Cass
JAMA Oncology
|
October 14, 2021
Poly(ADP-Ribose) Polymerase Inhibitors and Myeloid Neoplasm Risk-Clues to a Mechanistic Connection?
Christine Walsh, Ilana Cass
Journal of the National Cancer Institute
|
January 30, 2010
Ovarian cancer symptoms speak out--but what are they really saying?
Ilana Cass, Beth Y Karlan
Journal of Pediatric and Adolescent Gynecology
|
January 31, 2026
Changes in HPV vaccine uptake following the COVID Vaccine
Stephanie Harlow, Elizabeth Anderson, Ilana Cass
Obstetrics and Gynecology
|
July 25, 2012
Lessons learned in physician reentry
Ilana Cass, Leo A Gordon, Sarah Kilpatrick
Gynecologic Oncology
|
January 30, 2010
Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?
Ilana Cass, Ann Walts, Beth Y Karlan
Annals of Surgical Oncology
|
August 4, 2019
Requiem for Robotic Cancer Surgery? Not So Fast
John D Seigne, Ilana Cass, Sandra L Wong
JAMIA Open
|
February 11, 2022
Prenatal telemedicine during COVID-19: patterns of use and barriers to access
Allie Morgan, Daisy Goodman, Julia Vinagolu-Baur, et al.
Menopause (New York, N.Y.)
|
December 22, 2020
Short-term impact of surgically induced menopause on cognitive function and wellbeing in women at high risk for ovarian cancer following risk-reducing bilateral salpingo-oophorectomy
Heidi Chang, Daniella Kamara, Catherine Bresee, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Cancer
|
July 15, 2009
The search for meaning-symptoms and transvaginal sonography screening for ovarian cancer: silent no more
Ilana Cass
JAMA Network Open
|
March 31, 2026
Patient Preferences for Ovarian Cancer Risk-Reducing Treatments Revealed Through Choice Experiments
Ilana Cass
JAMA Oncology
|
October 14, 2021
Poly(ADP-Ribose) Polymerase Inhibitors and Myeloid Neoplasm Risk-Clues to a Mechanistic Connection?
Christine Walsh, Ilana Cass
Journal of the National Cancer Institute
|
January 30, 2010
Ovarian cancer symptoms speak out--but what are they really saying?
Ilana Cass, Beth Y Karlan
Journal of Pediatric and Adolescent Gynecology
|
January 31, 2026
Changes in HPV vaccine uptake following the COVID Vaccine
Stephanie Harlow, Elizabeth Anderson, Ilana Cass
Obstetrics and Gynecology
|
July 25, 2012
Lessons learned in physician reentry
Ilana Cass, Leo A Gordon, Sarah Kilpatrick
Gynecologic Oncology
|
January 30, 2010
Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?
Ilana Cass, Ann Walts, Beth Y Karlan
Annals of Surgical Oncology
|
August 4, 2019
Requiem for Robotic Cancer Surgery? Not So Fast
John D Seigne, Ilana Cass, Sandra L Wong
JAMIA Open
|
February 11, 2022
Prenatal telemedicine during COVID-19: patterns of use and barriers to access
Allie Morgan, Daisy Goodman, Julia Vinagolu-Baur, et al.
Menopause (New York, N.Y.)
|
December 22, 2020
Short-term impact of surgically induced menopause on cognitive function and wellbeing in women at high risk for ovarian cancer following risk-reducing bilateral salpingo-oophorectomy
Heidi Chang, Daniella Kamara, Catherine Bresee, et al.
Page
of 6